Thomas Munk Laursen

Thomas Munk Laursen

Auto-generated profile, based on publicly available information

Thomas Munk Laursen

Aarhus Universitet, National Centre for Register-based Research, Aarhus, Denmark

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 March 2014 in Annual Review of Clinical Psychology
Verified
Journal Article
Closed access
TLThomas Munk Laursen
Thomas Munk Laursen
MNMerete Nordentoft
Merete Nordentoft
PMPreben Bo Mortensen
Preben Bo Mortensen
Schizophrenia is often referred to as one of the most severe mental disorders, primarily because of the very high mortality rates of those with the disorder. This article reviews the literature on excess early mortality in persons with schizophrenia and suggests reasons for the high mortality as well as possible ways to reduce it. Persons with schizophrenia have an exceptionally short life expectancy. High mortality is found in all age groups, resulting in a life expectancy of approximately 20 years below that of the general population. Evidence suggests that persons with schizophrenia may not have seen the same improvement in life expectancy as the general population during the past decades. Thus, the mortality gap not only persists but may actually have increased. The most urgent research agenda concerns primary candidates for modifiable risk factors contributing to this excess mortality, i.e., side effects of treatment and lifestyle factors, as well as sufficient prevention and treatment of physical comorbidity.

26 January 2017 in World Psychiatry
Verified
Journal Article
Open access
PDF file
NLNancy H. Liu
Nancy H. Liu
GDGail L. Daumit
Gail L. Daumit
TDTarun Dua
Tarun Dua
RARalph Aquila
Ralph Aquila
Fiona CharlsonFiona Charlson
Fiona Charlson
SSShekhar Saxena
Shekhar Saxena
Excess mortality in persons with severe mental disorders (SMD) is a major public health challenge that warrants action. The number and scope of truly tested interventions in this area remain limited, and strategies for implementation and scaling up of programmes with a strong evidence base are scarce. Furthermore, the majority of available interventions focus on a single or an otherwise limited number of risk factors. Here we present a multilevel model highlighting risk factors for excess mortality in persons with SMD at the individual, health system and socio‐environmental levels. Informed by that model, we describe a comprehensive framework that may be useful for designing, implementing and evaluating interventions and programmes to reduce excess mortality in persons with SMD. This framework includes individual‐focused, health system‐focused, and community level and policy‐focused interventions. Incorporating lessons learned from the multilevel model of risk and the comprehensive intervention framework, we identify priorities for clinical practice, policy and research agendas.

6 December 2006 in JAMA
Verified
Journal Article
Open access
PDF file
TMTrine Munk-Olsen
Trine Munk-Olsen
TLThomas Munk Laursen
Thomas Munk Laursen
CPCarsten Bøcker Pedersen
Carsten Bøcker Pedersen
OMOle Mors
Ole Mors
PMPreben Bo Mortensen
Preben Bo Mortensen
Postpartum depression is a serious mental health problem for women and their families,1 with an estimated prevalence of about 10% to 15% among mothers.2,3 Postpartum mental disorders also include more severe postpartum psychoses with a prevalence of about 1 per 1000 births.4,5 Such episodes require close attention, often including hospitalization, both because of the severity of symptoms and because these conditions are potentially life-threatening to both the woman and her newborn child.6 Previous studies have identified primiparity as a risk factor for postpartum psychoses,7-10 and Kendell et al4 pointed out that the increased risk among primiparous women could not be attributed to the avoidance of further pregnancies by mothers who had a puerperal psychosis after their first birth.

25 January 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MNMerete Nordentoft
Merete Nordentoft
KWKristian Wahlbeck
Kristian Wahlbeck
JHJonas Hällgren
Jonas Hällgren
JWJeanette Westman
Jeanette Westman
UOUrban Osby
Urban Osby
TLThomas Munk Laursen
Thomas Munk Laursen
Excess mortality among patients with severe mental disorders has not previously been investigated in detail in large complete national populations. To investigate the excess mortality in different diagnostic categories due to suicide and other external causes of death, and due to specific causes in connection with diseases and medical conditions. In longitudinal national psychiatric case registers from Denmark, Finland, and Sweden, a cohort of 270,770 recent-onset patients, who at least once during the period 2000 to 2006 were admitted due to a psychiatric disorder, were followed until death or the end of 2006. They were followed for 912,279 person years, and 28,088 deaths were analyzed. Life expectancy and standardized cause-specific mortality rates were estimated in each diagnostic group in all three countries. The life expectancy was generally approximately 15 years shorter for women and 20 years shorter for men, compared to the general population. Mortality due to diseases and medical conditions was increased two- to three-fold, while excess mortality from external causes ranged from three- to 77-fold. Mortality due to diseases and medical conditions was generally lowest in patients with affective disorders and highest in patients with substance abuse and personality disorders, while mortality due to suicide was highest in patients with affective disorders and personality disorders, and mortality due to other external causes was highest in patients with substance abuse. These alarming figures call for action in order to prevent the high mortality.

1 November 2019 in The Lancet
Verified
Journal Article
Closed access
OPOleguer Plana-Ripoll
Oleguer Plana-Ripoll
CPCarsten Bøcker Pedersen
Carsten Bøcker Pedersen
EAEsben Agerbo
Esben Agerbo
YHYan Holtz
Yan Holtz
AEAnnette Erlangsen
Annette Erlangsen
TLThomas M Laursen
Thomas M Laursen

1 March 2019 in JAMA Psychiatry
Verified
Journal Article
Closed access
PDF file
OPOleguer Plana-Ripoll
Oleguer Plana-Ripoll
CPCarsten Bøcker Pedersen
Carsten Bøcker Pedersen
YHYan Holtz
Yan Holtz
MBMichael Eriksen Benros
Michael Eriksen Benros
SDSøren Dalsgaard
Søren Dalsgaard
JMJohn McGrath
John McGrath
Comorbidity, defined as the presence of 1 or more disorders in relation to an index disorder,1 has been the focus of a substantial body of research during the 5 decades since the term was introduced.2 In the mental health field, it is widely acknowledged that individuals treated for incident mental disorders are at increased risk of subsequently developing other mental disorders.3 Based on a survey of mental health among adolescents 13 to 17 years of age, Kessler et al4 reported that 27.9% of respondents met criteria for 2 or more disorders. Several community surveys have reported that, among respondents with at least 1 mental disorder, 45% to 54% have 1 or more additional lifetime diagnoses.3,5,6